This work was supported in part by National Heart, Lung, and Blood Institute Grants RO1-HL-99507, HL-114120, HL-131017, HL138023, and UO1-HL-134764 (to J. Zhang) and by American Heart Association Scientific Development Grant 17SDG33670677 (to R. Kannappan).

1. Comet Assay
<ol>
	<li>Reagent preparation
	<ol>
		<li>For low-melting-point agarose, place 500 mg of low-melting agarose in 100 mL of DNA-/RNA-free water. Heat the bottle in a microwave oven until the agarose dissolves. Place the bottle in a 37 &#176;C water bath until needed. 
		NOTE: For further reading, see Azqueta et al., who studied the effects of agarose concentration on the DNA-unwinding time and several electrophoresis factors23.</li>
		<li>Dilute SYBR green DNA dye in Tris-EDTA (TE) Buffer at a 1:10,000 ratio to obtain a 1x working stock dye solution. This dye is light-sensitive, so store it in a dark place.</li>
		<li>For the cell lysis buffer, dissolve 100 mL of lysis buffer (2.5 M NaCl, 0.1 M EDTA, 10 mM Tris, 1% Triton X-100) in deionized water (DI H2O). Then, add 10 M NaOH to adjust the pH to 10.0. Cool the buffer to 4 &#176;C.</li>
		<li>For the alkaline DNA-unwinding/electrophoresis running buffer, dissolve 1 L of alkaline solution (0.3 M NaOH, 1 mM EDTA) in DI H2O. Cool the buffer to 4 &#176;C. Make sure the pH &#62;13.</li>
		<li>For precoated comet slides, place a few drops of 0.5% agarose on a glass slide. Immediately, using the flat surface of another slide, spread the agarose to form a thin layer of agarose coating. 
		NOTE: Dry the slides before using.</li>
		<li>For iPS cell culture, briefly culture iPS cells in basement-membrane-matrix-coated (see Table of Materials) culture plates in mTESR1 culture medium until confluency is reached. 
		NOTE: Human-cardiac-fibroblast-derived iPS cells were used in this protocol. The reprogramming of iPS cell derivation and culture conditions is described in recent articles from our research group12,13,21.</li>
	</ol>
	</li>
	<li>Sample preparation
	<ol>
		<li>Discard the culture medium and wash the cells. Dissociate the cells using detachment solution (see Table of Materials). Wash the cell pellet with phosphate-buffered saline (PBS) and resuspend the cells in PBS at 1 x 105 cells/mL.</li>
	</ol>
	</li>
	<li>Sample slide preparation 
	NOTE: Perform the following steps under low-light conditions to avoid ultraviolet-light-induced cell damage.
	<ol>
		<li>Mix 10 &#956;L of cell suspension and 90 &#956;L of agarose solution (1:10 ratio) in a tube. Place the tube in a 37 &#176;C water bath to prevent the agarose from solidifying.</li>
		<li>Mix the solutions without introducing air bubbles and pipette 70 &#956;L/spot onto the precoated comet slide. Using a pipette tip, spread the cell agarose mixture to form a thin layer. Place the slide in 4 &#176;C for 15 min.</li>
		<li>In a container, completely submerge the slide in cold lysis buffer. Place the container in the dark at 4 &#176;C for 1 h.</li>
		<li>Replace the lysis buffer with cold alkaline solution. Make sure the slides are completely submerged. Place the container in the dark at 4 &#176;C for 30 min.</li>
	</ol>
	</li>
	<li>Electrophoresis
	<ol>
		<li>Place the slide in a horizontal electrophoresis tank. Fill the tank with cold alkaline electrophoresis buffer until the slides are completely submerged. Apply voltage at 1 V/cm for 15 to 30 min. 
		NOTE: Total voltage = distance between the electrodes x 1 V</li>
		<li>In a container, completely submerge the slide in cold DI H2O. After 2 min, remove the DI H2O and add fresh DI H2O. Repeat this step.</li>
		<li>Replace the DI H2O with cold 70% ethanol. Wait 5 min. Gently remove the slide, do not tilt it, and let it air-dry.</li>
		<li>Once dried, add 100 &#956;L of diluted DNA dye to each spot. Wait 15 min at room temperature. Using a FITC filter in an epifluorescence microscope, take images of 50 to 100 comets in total per sample.</li>
	</ol>
	</li>
	<li>Image analysis and calculation of the results
	<ol>
		<li>For scoring the comets, use the National Institutes of Health&#8217;s (NIH) ImageJ with comet assay plugin (download ImageJ here: https://imagej.nih.gov/ij/download.html; download the plugin here: https://www.med.unc.edu/microscopy/resources/imagej-plugins-and-macros/comet-assay/). 
		NOTE: The plugin comes with a PDF instruction which contains all details to perform the analysis. Additionally, screenshots of the comet analysis are shown in Figure 2A-C. Representative comet images of control and doxorubicin (Doxo)-treated iPS cells and the quantification of the comets are shown in Figure 3A-C.</li>
	</ol>
	</li>
</ol>
2. DNA Damage Response
<ol>
	<li>Sample and reagent preparation
	<ol>
		<li>For an iPS-CM cell culture, culture iPS-CM cells in basement-membrane-matrix-coated (see Table of Materials) culture plates in RPMI medium supplemented with B-27 (CMM) until confluency is reached. 
		NOTE: Human-iPS-cell-derived cardiomyocytes were used in this protocol. The protocol for iPS cell differentiation into cardiomyocytes can be found in recent articles from our research group12,13,21.</li>
		<li>Seed iPS-CMs in chamber slides.
		<ol>
			<li>Discard the culture medium from the iPS-CM wells. Wash the cells three times with PBS.</li>
			<li>Add 1 mL of 0.25% trypsin per well and incubate at 37 &#176;C for 5 min. Check the plate under a microscope for cell detachment. Add 1 mL of CMM to stop the trypsin.</li>
			<li>Place cell suspension in a 15 mL tube and centrifuge for 5 min at 4 &#176;C and 200 x g. Discard the medium, add 1 mL of CMM, and resuspend the cells. Count the cells and adjust the cell count to obtain 20 x 105 cells in 1.6 mL of CMM.</li>
			<li>Seed 200 &#181;L of cell suspension per well of the 8-well chamber slide (see Table of Materials). Tap the slide gently to spread the cells around the well and incubate at 37 &#176;C.</li>
		</ol>
		</li>
		<li>For the iPS-CM doxorubicin treatment, discard the culture medium from the iPS-CM wells. Wash the cells with PBS. Treat the cells with 1 &#956;M doxorubicin and CMM for 4 h. Aspirate the medium and wash the cells with PBS.</li>
		<li>For the blocking buffer, prepare 10 mL of bovine serum albumin (BSA) solution containing 3% BSA and 0.05% Triton X-100. To prepare 10 mL of blocking buffer, add 1 mL of normal donkey serum to 9 mL of prepared BSA solution.</li>
		<li>For the primary antibody solution, add 1 &#956;L of anti-rabbit phospho-histone H2A.X (Ser139) antibody to 200 &#956;L of blocking buffer.</li>
		<li>For the secondary antibody mix, add 1 &#956;L each of fluorochrome-conjugated anti-rabbit secondary antibody, DAPI, and fluorochrome-conjugated phalloidin to 200 &#956;L of blocking buffer.</li>
	</ol>
	</li>
	<li>Immunolabeling
	<ol>
		<li>Wash the cells three times with PBS and add 200 &#956;L of freshly prepared 4% paraformaldehyde (PFA) to each well. Fix the cells for 20 min in the dark at room temperature. Wash the cells with PBS.</li>
		<li>Remove the PBS and add 200 &#956;L of blocking buffer per well and block for 30 min in a humidified chamber at room temperature. Remove the blocking buffer and add 200 &#956;L of primary antibody solution. Incubate for 45 min in a dark, humidified chamber at room temperature. Then, wash the wells three times with PBS.</li>
		<li>Remove the PBS and add 200 &#956;L of secondary antibody mix. Incubate for 45 min in a dark, humidified chamber at room temperature. Then, wash the wells three times with PBS. Wash with DI H2O before mounting them with antifade. Place a coverglass and store the slides in the dark at 4 &#176;C.</li>
		<li>Using an epifluorescence microscope, take three to five images of random fields per sample, as shown in Figure 4A, and proceed to image analysis.</li>
	</ol>
	</li>
	<li>Counting of the DDR foci
	<ol>
		<li>Download and install CellProfiler24 (http://cellprofiler.org).</li>
		<li>NOTE: Image processing in this study was performed using CellProfiler version 2.1.1. Tutorials for CellProfiler that were used can be found elsewhere (https://www.youtube.com/watch?v=PvhRL9xpduk&#38;list=PL7CC87670239B4D10). If a newer version of CellProfiler is being used, the pipeline might require minor adaptations.</li>
		<li>Download the pipeline punctae_gH2AX.cpipe. Select File &#62; Import &#62; Pipeline from the file and choose punctae_gH2AX.cpipe.</li>
		<li>Drag-and-drop the folder containing the acquired images of &#947;H2A.X foci to the File list window in the Input modules/Images section for analysis (Figure 5A). Then, follow the instructions as shown in Figure 5A-L.</li>
		<li>Set the following parameters for the images:
		<ol>
			<li>Drag the desired image for analysis onto the File list. Under Input modules, select Images (see Figure 5A for module settings). In Input modules, select Metadata (see Figure 5B for module settings). In Input modules, select NamesAndTypes (see Figure 5C for module settings).</li>
			<li>For Groups, select no. In Analysis modules, select ColorToGray (see Figure 5D for module settings).</li>
		</ol>
		</li>
		<li>In Analysis modules, select Smooth (see Figure 5E for module settings). 
		NOTE: This value may need to be optimized, depending on the image resolution.</li>
		<li>In Analysis modules, select IdentifyPrimaryObjects (see Figure 5F for module settings). 
		NOTE: Optimize these values to make sure the whole nucleus is selected. After this step, the computer may lag.</li>
		<li>In Analysis modules, select Smooth (see Figure 5G for module settings). 
		NOTE: This value may need to be optimized, depending on the image resolution.</li>
		<li>In Analysis modules, select EnhanceOrSuppressFeatures (see Figure 5H for module settings).</li>
		<li>In Analysis modules, select IdentifyPrimaryObjects (see Figure 5I for module settings). 
		NOTE: Optimize these values to make sure the punctae are selected. After this step, the computer may lag again.
		<ol>
			<li>In Analysis modules, select RelateObjects (see Figure 5J for module settings). In Analysis modules, select ClassifyObjects (see Figure 5K for module settings). In Analysis modules, select ExportToSpreadsheet (see Figure 5L for module settings).</li>
			<li>Click Analyze Images at the bottom left panel to perform image analysis. At the successful completion of the analysis, several images are generated (Figure 6A-F). 
			NOTE: Users should save these images for future reference.</li>
			<li>Note the .csv file containing the quantitative data for further analysis that is generated and saved in the appropriate location on the computer. In the spreadsheet called MyExpt_Image, columns B and D will have the number of nuclei that have up to five and more punctae, respectively. Add columns B and D to get the total number of nuclei.</li>
		</ol>
		</li>
		<li>Repeat step 2.3.3 - 2.3.8 for all images (change the MyExpt_ filename before every analysis). Plots can be made for assessing DNA integrity, as shown in Figure 4C.</li>
	</ol>
	</li>
</ol>

<ol>
	<li>Bolli, R., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Cardiac+stem+cells+in+patients+with+ischaemic+cardiomyopathy+(SCIPIO):+initial+results+of+a+randomised+phase+1+trial.">Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial.</a> The Lancet. 378 (9806), 1847-1857 (2011).</li><li>Makkar, R. R., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Intracoronary+cardiosphere-derived+cells+for+heart+regeneration+after+myocardial+infarction+(CADUCEUS):+a+prospective,+randomised+phase+1+trial.">Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial.</a> The Lancet. 379 (9819), 895-904 (2012).</li><li>Tomita, Y., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Cardiac+neural+crest+cells+contribute+to+the+dormant+multipotent+stem+cell+in+the+mammalian+heart.">Cardiac neural crest cells contribute to the dormant multipotent stem cell in the mammalian heart.</a> Journal of Cell Biology. 170 (7), 1135-1146 (2005).</li><li>Oyama, T., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Cardiac+side+population+cells+have+a+potential+to+migrate+and+differentiate+into+cardiomyocytes+in+vitro+and+in+vivo.">Cardiac side population cells have a potential to migrate and differentiate into cardiomyocytes in vitro and in vivo.</a> Journal of Cell Biology. 176 (3), 329-341 (2007).</li><li>Fischer, K. M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Enhancement+of+myocardial+regeneration+through+genetic+engineering+of+cardiac+progenitor+cells+expressing+Pim-1+kinase.">Enhancement of myocardial regeneration through genetic engineering of cardiac progenitor cells expressing Pim-1 kinase.</a> Circulation. 120 (21), 2077-2087 (2009).</li><li>Cottage, C. T., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Cardiac+progenitor+cell+cycling+stimulated+by+pim-1+kinase.">Cardiac progenitor cell cycling stimulated by pim-1 kinase.</a> Circulation Research. 106 (5), 891-901 (2010).</li><li>Angert, D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Repair+of+the+injured+adult+heart+involves+new+myocytes+potentially+derived+from+resident+cardiac+stem+cells.">Repair of the injured adult heart involves new myocytes potentially derived from resident cardiac stem cells.</a> Circulation Research. 108 (10), 1226-1237 (2011).</li><li>Kannappan, R., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=p53+Modulates+the+Fate+of+Cardiac+Progenitor+Cells+Ex+vivo+and+in+the+Diabetic+Heart+In+vivo.">p53 Modulates the Fate of Cardiac Progenitor Cells Ex vivo and in the Diabetic Heart In vivo.</a> EBioMedicine. 16, 224-237 (2017).</li><li>Hatzistergos, K. E., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Bone+marrow+mesenchymal+stem+cells+stimulate+cardiac+stem+cell+proliferation+and+differentiation.">Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation.</a> Circulation Research. 107 (7), 913-922 (2010).</li><li>Okita, K., Yamanaka, S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Induced+pluripotent+stem+cells:+opportunities+and+challenges.">Induced pluripotent stem cells: opportunities and challenges.</a> Philosophical Transactions of the Royal Society B Biological Sciences. 366 (1575), 2198-2207 (2011).</li><li>Zhang, J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Functional+cardiomyocytes+derived+from+human+induced+pluripotent+stem+cells.">Functional cardiomyocytes derived from human induced pluripotent stem cells.</a> Circulation Research. 104 (4), e30-e41 (2009).</li><li>Ye, L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Cardiac+repair+in+a+porcine+model+of+acute+myocardial+infarction+with+human+induced+pluripotent+stem+cell-derived+cardiovascular+cells.">Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells.</a> Cell Stem Cell. 15 (6), 750-761 (2014).</li><li>Zhang, L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Derivation+and+high+engraftment+of+patient-specific+cardiomyocyte+sheet+using+induced+pluripotent+stem+cells+generated+from+adult+cardiac+fibroblast.">Derivation and high engraftment of patient-specific cardiomyocyte sheet using induced pluripotent stem cells generated from adult cardiac fibroblast.</a> Circulation: Heart Failure. 8 (1), 156-166 (2015).</li><li>Hirakawa, K., Midorikawa, K., Oikawa, S., Kawanishi, S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Carcinogenic+semicarbazide+induces+sequence-specific+DNA+damage+through+the+generation+of+reactive+oxygen+species+and+the+derived+organic+radicals.">Carcinogenic semicarbazide induces sequence-specific DNA damage through the generation of reactive oxygen species and the derived organic radicals.</a> Mutation Research. 536 (1-2), 91-101 (2003).</li><li>Martinez, G. R., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Oxidative+and+alkylating+damage+in+DNA.">Oxidative and alkylating damage in DNA.</a> Mutation Research. 544 (2-3), 115-127 (2003).</li><li>Valko, M., Rhodes, C. J., Moncol, J., Izakovic, M., Mazur, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Free+radicals,+metals+and+antioxidants+in+oxidative+stress-induced+cancer.">Free radicals, metals and antioxidants in oxidative stress-induced cancer.</a> Chemico-Biological Interactions. 160 (1), 1-40 (2006).</li><li>Wiseman, H., Halliwell, B. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Damage+to+DNA+by+reactive+oxygen+and+nitrogen+species:+role+in+inflammatory+disease+and+progression+to+cancer.">Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer.</a> Biochemical Journal. 313 (Pt 1), 17-29 (1996).</li><li>Ostling, O., Johanson, K. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Microelectrophoretic+study+of+radiation-induced+DNA+damages+in+individual+mammalian+cells.">Microelectrophoretic study of radiation-induced DNA damages in individual mammalian cells.</a> Biochemical and Biophysical Research Communications. 123 (1), 291-298 (1984).</li><li>Singh, N. P., McCoy, M. T., Tice, R. R., Schneider, E. L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+simple+technique+for+quantitation+of+low+levels+of+DNA+damage+in+individual+cells.">A simple technique for quantitation of low levels of DNA damage in individual cells.</a> Experimental Cell Research. 175 (1), 184-191 (1988).</li><li>Goichberg, P., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Age-associated+defects+in+EphA2+signaling+impair+the+migration+of+human+cardiac+progenitor+cells.">Age-associated defects in EphA2 signaling impair the migration of human cardiac progenitor cells.</a> Circulation. 128 (20), 2211-2223 (2013).</li><li>Kannappan, R., Mattapally, S., Wagle, P. A., Zhang, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Transactivation+domain+of+p53+regulates+DNA+repair+and+integrity+in+human+iPS+cells.">Transactivation domain of p53 regulates DNA repair and integrity in human iPS cells.</a> American Journal of Physiology-Heart and Circulatory Physiology. , (2018).</li><li>Al-Baker, E. A., Oshin, M., Hutchison, C. J., Kill, I. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Analysis+of+UV-induced+damage+and+repair+in+young+and+senescent+human+dermal+fibroblasts+using+the+comet+assay.">Analysis of UV-induced damage and repair in young and senescent human dermal fibroblasts using the comet assay.</a> Mechanisms of Ageing and Development. 126 (6-7), 664-672 (2005).</li><li>Azqueta, A., Gutzkow, K. B., Brunborg, G., Collins, A. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Towards+a+more+reliable+comet+assay:+optimising+agarose+concentration,+unwinding+time+and+electrophoresis+conditions.">Towards a more reliable comet assay: optimising agarose concentration, unwinding time and electrophoresis conditions.</a> Mutation Research. 724 (1-2), 41-45 (2011).</li><li>Carpenter, A. E., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=CellProfiler:+image+analysis+software+for+identifying+and+quantifying+cell+phenotypes.">CellProfiler: image analysis software for identifying and quantifying cell phenotypes.</a> Genome Biology. 7 (10), R100 (2006).</li><li>Paradis, A. N., Gay, M. S., Zhang, L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Binucleation+of+cardiomyocytes:+the+transition+from+a+proliferative+to+a+terminally+differentiated+state.">Binucleation of cardiomyocytes: the transition from a proliferative to a terminally differentiated state.</a> Drug Discovery Today. 19 (5), 602-609 (2014).</li></ol>

The authors have nothing to disclose.

DNA integrity portrays cell integrity. Cells with damaged DNA are frequently in stress and eventually lose their integrity. The integrity of stem and stem-cell-derived cells that are being propagated for the purpose of transplantation is principal for the cells to perform their desired function. Transplanting cells with damaged DNA would result in a poor engraftment rate and performance of the cell8,20. Therefore, examining the DNA integrity prior to cell transpl...

Experimental and clinical evidence demonstrates that cell transplantation can moderately improve the left ventricle contractile performance of failing hearts1,2,3,4,5,6,7,8,9. Recent advances have opened further appealing opportunities for cardiovascular regeneration; these include the forced expression of reprogramming factors in somatic cells to induce pluripotency and differentiate these induced pluripotent stem cells (iPSC) into different cardiac lineages, importantly cardiomyocyte (CM)10,11,12,13. The hereditary material in every cell, including the artificially generated iPSCs and iPSC-derived CM (iPS-CM), is DNA. The genetic instructions stored in DNA dictates the growth, development, and function of cells, tissues, organs, and organisms. DNA is not inert; cell metabolites, such as reactive oxygen, carbonyl, and nitrogen species, and alkylating agents can cause DNA damage in vitro and in vivo14,15,16,17. Importantly, DNA damage occurs intuitively in every cell, with a significant frequency. If these damages are not corrected, it will lead to DNA mutation, cellular senescence, the loss of DNA and cell integrity, and possibly, diseases, including life-threatening cancers. Therefore, retaining DNA integrity is essential to any cell, especially iPSCs, that has enormous potential in the clinic.
For assessing the quantity and integrity of isolated genomic DNA, expensive equipment is available on the market. However, there are no simple and cost-effective methods to assess the DNA integrity in cells without isolating the cells. Moreover, user-induced DNA degradation during DNA isolation is one of the major drawbacks in using these methods. The single-cell gel electrophoresis (known as comet assay)18,19 and &#947;H2A.X immunolabeling8 techniques are fundamental approaches in research labs for assessing DNA damage. These two methods do not require expensive equipment or isolated genomic DNA to analyze DNA integrity8,20,21. Since, these techniques have been performed with whole cells; user-induced DNA/RNA/protein degradation during the sample preparation will not affect these protocols. Here, to assess the DNA damage and DNA damage response in stem and stem-cell-derived cells, we provide step-by-step protocols to perform both the comet assay and &#947;H2A.X immunolabeling. Moreover, combining these two approaches, we propose a naive assessment that can be used to evaluate the cell&#39;s suitability for transplantation.
The comet assay, or single-cell gel electrophoresis, measures the DNA breaks in cells. Cells embedded in low-melting agarose are lysed to form nucleoids containing supercoiled DNA. Upon electrophoresis, small pieces of fragmented DNA and broken DNA strands migrate through the agarose pores, whereas the intact DNA, due to their enormous size and their conjugation with the matrix protein, will have a restricted migration. The pattern of stained DNA under a fluorescence microscope mimics a comet. The comet head contains intact DNA and the tail is composed of fragments and broken DNA strands. The fraction of DNA damage can be measured by the fluorescence intensity of the damaged DNA (comet tail) relative to the intact DNA (comet head) intensity. The parameter tail moment can be calculated as shown in Figure 1.
DNA damage induces the phosphorylation of histone H2A.X (&#947;H2A.X) at Ser139 by ATM, ATR, and DNA-PK kinases. The phosphorylation and recruitment of H2A.X at DNA strand breaks is called DNA damage response (DDR) and happens rapidly after DNA is damaged. Following this process, checkpoint-mediated cell cycle arrest and DNA repair processes are initiated. After the successful completion of DNA repair, &#947;H2A.X is dephosphorylated and inactivated by phosphatases. Prolonged and multiple DNA strand breaks lead to the accumulation of &#947;H2A.X foci in DNA. This indicates the cell&#39;s inability to repair the DNA damage and the loss of DNA integrity. These &#947;H2A.X foci in DNA can be identified by and the number of DDR foci can be counted using the protocol in section 2.

<table>
	<tbody>
		<tr>
			<td>0.25% Trypsin</td>
			<td>Corning</td>
			<td>25200056</td>
			<td></td>
		</tr>
		<tr>
			<td>8-well chamber slide</td>
			<td>Millicell</td>
			<td>PEZGS0816</td>
			<td></td>
		</tr>
		<tr>
			<td>Accutase</td>
			<td>Stemcell Technologies</td>
			<td>7920</td>
			<td>Cell detachment solution</td>
		</tr>
		<tr>
			<td>Alexa Fluor 488 AffiniPure 
			Donkey Anti-Rabbit IgG</td>
			<td>Jackson Immuno 
			Research Laboratories</td>
			<td>711-545-152 
			(RRID: AB_2313584)</td>
			<td></td>
		</tr>
		<tr>
			<td>Bovine Serum Albumin</td>
			<td>Sigma-Aldrich</td>
			<td>A7906</td>
			<td></td>
		</tr>
		<tr>
			<td>Cy3 AffiniPure Donkey Anti-Rabbit IgG</td>
			<td>Jackson Immuno 
			Research Laboratories</td>
			<td>711-165-152 
			(RRID:AB_2307443)</td>
			<td></td>
		</tr>
		<tr>
			<td>DAPI</td>
			<td>Sigma-Aldrich</td>
			<td>D9564</td>
			<td></td>
		</tr>
		<tr>
			<td>Gibco B-27 Supplement, Serum Free,</td>
			<td>Gibco</td>
			<td>17504-044</td>
			<td></td>
		</tr>
		<tr>
			<td>Matrigel growth factor reduced</td>
			<td>Corning</td>
			<td>354230</td>
			<td></td>
		</tr>
		<tr>
			<td>mTeSR1</td>
			<td>Stemcell Technologies</td>
			<td>85850</td>
			<td></td>
		</tr>
		<tr>
			<td>PhalloidinA488</td>
			<td>Life Technology</td>
			<td>A12379</td>
			<td></td>
		</tr>
		<tr>
			<td>Phospho-Histone H2A.X (Ser139) Antibody</td>
			<td>Cell Signaling Technology</td>
			<td>2577 (RRID: AB_2118010)</td>
			<td></td>
		</tr>
		<tr>
			<td>RPMI</td>
			<td>Gibco</td>
			<td>11875-093</td>
			<td></td>
		</tr>
		<tr>
			<td>SYBR&#160;Green I nucleic acid gel stain</td>
			<td>Sigma-Aldrich</td>
			<td>S9430</td>
			<td></td>
		</tr>
		<tr>
			<td>Triton X-100</td>
			<td>Fisher scientific</td>
			<td>BP151-100</td>
			<td></td>
		</tr>
		<tr>
			<td>UltraPure Low melting Point Agarose</td>
			<td>Invitrogen</td>
			<td>16520050</td>
			<td></td>
		</tr>
		<tr>
			<td>Vectashield</td>
			<td>Vector Laboratories</td>
			<td>H-1000</td>
			<td>Antifade</td>
		</tr>
	</tbody>
</table>

assessing stem cell dna integrity for cardiac cell therapy

Stem and stem-cell-derived cells have immense potential as a regenerative therapy for various degenerative diseases. DNA is the storehouse of genetic data in all cells, including stem cells, and its integrity is fundamental to its regenerative ability. Stem cells undergo rapid propagation in labs to achieve the necessary numbers for transplantation. Accelerated cell growth leads to the loss of DNA integrity by accumulated metabolites, such as reactive oxygen, carbonyl, and alkylating agents. Transplanting these cells would result in poor engraftment and regeneration of the deteriorating organ. Moreover, transplanting DNA-damaged cells leads to mutations, DNA instability, cellular senescence, and possibly, life-threatening diseases such as cancer. Therefore, there is an immediate need for a quality control method to evaluate the cell's suitability for transplantation. Here, we provide step-by-step protocols for the assessment of the DNA integrity of stem cells prior to cell transplantation.

Human induced pluripotent stem cells were cultured, and the DNA damage and the tail moment, which were used as a measure of DNA integrity, were analyzed by comet assay. iPS cells were embedded in low-melting-point agarose and placed on a glass slide. The cells were, then, treated with lysis buffer, followed by an alkaline solution, to obtain supercoiled DNA. Nucleoids were electrophoresed and comets were visualized by DNA dye (Figure 1A-D). T...

Watch this Scientific Journal Video about Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy at JoVE.com

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Kardiyak hücre tedavisi için kök hücre DNA bütünlük değerlendirilmesi

Here, we provide a detailed description of an experimental setup for an analysis of the assessment of DNA integrity in stem cells prior to cell transplantation.

Stem and stem-cell-derived cells have immense potential as a regenerative therapy for various degenerative diseases. DNA is the storehouse of genetic data ...

assessing-stem-cell-dna-integrity-for-cardiac-cell-therapy

Research

JoVE Journal

Genetics

7.6K Görüntüleme.  University of Alabama at Birmingham. Kardiyomiyopati gibi yenidoğan hastalıklarında, indüklenen pluripotent kök hücre kaynaklı hücreler kullanılarak rejeneratif tedavi nin büyük bir potansiyeli vardır. Ancak, in vitro hızlandırılmış hücre büyümesi reaktif oksijen türleri gibi birikmiş metabolitleri tarafından DNA hasarına yol açar. Bu DNA hasarlı hücrelerin nakli organın kötü engraftment ve rejenerasyon neden olur.Transplantasyon dan önce hücrelerin kalitesi değerlendirilmelidir. Burada k?...

Video: Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

The processing of most eukaryotic RNAs is mediated by RNA Binding Proteins (RBPs) with modular configurations, including an RNA recognition module, which specifically binds the pre-mRNA target and an effector domain. Previously, we have taken advantage of the unique RNA binding mode of the PUF domain in human Pumilio 1 to generate a programmable RNA binding scaffold, which was used to engineer various artificial RBPs to manipulate RNA metabolism. Here, a detailed protocol is described to construct Engineered Splicing Factors (ESFs) that are specifically designed to modulate the alternative splicing of target genes. The protocol includes how to design and construct a customized PUF scaffold for a specific RNA target, how to construct an ESF expression plasmid by fusing a designer PUF domain and an effector domain, and how to use ESFs to manipulate the splicing of target genes. In the representative results of this method, we have also described the common assays of ESF activities using splicing reporters, the application of ESF in cultured human cells, and the subsequent effect of splicing changes. By following the detailed protocols in this report, it is possible to design and generate ESFs for the regulation of different types of Alternative Splicing (AS), providing a new strategy to study splicing regulation and the function of different splicing isoforms. Moreover, by fusing different functional domains with a designed PUF domain, researchers can engineer artificial factors that target specific RNAs to manipulate various steps of RNA processing.

This report describes a bioengineering method to design and construct novel Artificial Splicing Factors (ASFs) that specifically modulate the splicing of target genes in mammalian cells. This method can be further expanded to engineer various artificial factors to manipulate other aspects of RNA metabolism.

Yapay Faktörler Mühendislik Özellikle İnsan Hücreleri alternatif bağlantı işleyin için

The processing of most eukaryotic RNAs is mediated by RNA Binding Proteins (RBPs) with modular configurations, including an RNA recognition module, which ...

Genetik

Using a Fluorescent PCR-capillary Gel Electrophoresis Technique to Genotype CRISPR/Cas9-mediated Knockout Mutants in a High-throughput Format

The development of programmable genome-editing tools has facilitated the use of reverse genetics to understand the roles specific genomic sequences play in the functioning of cells and whole organisms. This cause has been tremendously aided by the recent introduction of the CRISPR/Cas9 system-a versatile tool that allows researchers to manipulate the genome and transcriptome in order to, among other things, knock out, knock down, or knock in genes in a targeted manner. For the purpose of knocking out a gene, CRISPR/Cas9-mediated double-strand breaks recruit the non-homologous end-joining DNA repair pathway to introduce the frameshift-causing insertion or deletion of nucleotides at the break site. However, an individual guide RNA may cause undesirable off-target effects, and to rule these out, the use of multiple guide RNAs is necessary. This multiplicity of targets also means that a high-volume screening of clones is required, which in turn begs the use of an efficient high-throughput technique to genotype the knockout clones. Current genotyping techniques either suffer from inherent limitations or incur high cost, hence rendering them unsuitable for high-throughput purposes. Here, we detail the protocol for using fluorescent PCR, which uses genomic DNA from crude cell lysate as a template, and then resolving the PCR fragments via capillary gel electrophoresis. This technique is accurate enough to differentiate one base-pair difference between fragments and hence is adequate in indicating the presence or absence of a frameshift in the coding sequence of the targeted gene. This precise knowledge effectively precludes the need for a confirmatory sequencing step and allows users to save time and cost in the process. Moreover, this technique has proven to be versatile in genotyping various mammalian cells of various tissue origins targeted by guide RNAs against numerous genes, as shown here and elsewhere.

The genotyping technique described here, which couples fluorescent polymerase chain reaction (PCR) to capillary gel electrophoresis, allows for high-throughput genotyping of nuclease-mediated knockout clones. It circumvents limitations faced by other genotyping techniques and is more cost effective than sequencing methods.

CRISPR genotipine bir Floresan PCR kılcal jel elektroforezi Tekniği / yüksek verimli bir Format Nakavt Mutants Cas9 aracılı

The development of programmable genome-editing tools has facilitated the use of reverse genetics to understand the roles specific genomic sequences play ...

A Universal Protocol for Large-scale gRNA Library Production from any DNA Source

The popularity of the CRISPR/Cas9 system for both genome and epigenome engineering stems from its simplicity and adaptability. An effector (the Cas9 nuclease or a nuclease-dead dCas9 fusion protein) is targeted to a specific site in the genome by a small synthetic RNA known as the guide RNA, or gRNA. The bipartite nature of the CRISPR system enables its use in screening approaches since plasmid libraries containing expression cassettes of thousands of individual gRNAs can be used to interrogate many different sites in a single experiment. 
To date, gRNA sequences for the construction of libraries have been almost exclusively generated by oligonucleotide synthesis, which limits the achievable complexity of sequences in the library and is relatively cost-intensive. Here, a detailed protocol for CORALINA (comprehensive gRNA library generation through controlled nuclease activity), a simple and cost-effective method for the generation of highly complex gRNA libraries based on enzymatic digestion of input DNA, is described. Since CORALINA libraries can be generated from any source of DNA, plenty of options for customization exist, enabling a large variety of CRISPR-based screens.

Methods for generating large-scale gRNA libraries should be simple, efficient and cost-effective. We describe a protocol for the production of gRNA libraries based on enzymatic digestion of target DNA. This method, CORALINA (comprehensive gRNA library generation through controlled nuclease activity) presents an alternative to costly custom oligonucleotide synthesis.

Büyük ölçekli gRNA Kütüphane üretim herhangi bir DNA kaynaktan için evrensel bir iletişim kuralı

The popularity of the CRISPR/Cas9 system for both genome and epigenome engineering stems from its simplicity and adaptability. An effector (the Cas9 ...

Semi-quantitative Detection of RNA-dependent RNA Polymerase Activity of Human Telomerase Reverse Transcriptase Protein

Human telomerase reverse transcriptase (TERT) is the catalytic subunit of telomerase, and it elongates telomere through RNA-dependent DNA polymerase activity. Although TERT is named as a reverse transcriptase, structural and phylogenetic analyses of TERT demonstrate that TERT is a member of right-handed polymerases, and relates to viral RNA-dependent RNA polymerases (RdRPs) as well as viral reverse transcriptase. We firstly identified RdRP activity of human TERT that generates complementary RNA stand to a template non-coding RNA and contributes to RNA silencing in cancer cells. To analyze this non-canonical enzymatic activity, we developed RdRP assay with recombinant TERT in 2009, thereafter established in vitro RdRP assay for endogenous TERT. In this manuscript, we describe the latter method. Briefly, TERT immune complexes are isolated from cells, and incubated with template RNA and rNTPs including radioactive rNTP for RdRP reaction. To eliminate single-stranded RNA, reaction products are treated with RNase I, and the final products are analyzed with polyacrylamide gel electrophoresis. Radiolabeled RdRP products can be detected by autoradiography after overnight exposure.

Human telomerase reverse transcriptase (TERT) synthesizes not only telomeric DNA but also double-stranded RNA through RNA-dependent RNA polymerase activity. Here, we describe a newly established assay to detect RNA-dependent RNA polymerase activity of endogenous TERT.

İnsan revers transkriptaz protein RNA'ya bağımlı RNA polimeraz aktivitesinin yarı kantitatif algılama

Human telomerase reverse transcriptase (TERT) is the catalytic subunit of telomerase, and it elongates telomere through RNA-dependent DNA polymerase ...

Profiling DNA Replication Timing Using Zebrafish as an In Vivo Model System

DNA replication timing is an important cellular characteristic, exhibiting significant relationships with chromatin structure, transcription, and DNA mutation rates. Changes in replication timing occur during development and in cancer, but the role replication timing plays in development and disease is not known. Zebrafish were recently established as an in vivo model system to study replication timing. Here is detailed the protocols for using the zebrafish to determine DNA replication timing. After sorting cells from embryos and adult zebrafish, high-resolution genome-wide DNA replication timing patterns can be constructed by determining changes in DNA copy number through analysis of next generation sequencing data. The zebrafish model system allows for evaluation of the replication timing changes that occur in vivo throughout development, and can also be used to assess changes in individual cell types, disease models, or mutant lines. These methods will enable studies investigating the mechanisms and determinants of replication timing establishment and maintenance during development, the role replication timing plays in mutations and tumorigenesis, and the effects of perturbing replication timing on development and disease.

Profiling DNA Replication Timing Using Zebrafish as an In Vivo Model System

Zebrafish were recently used as an in vivo model system to study DNA replication timing during development. Here is detailed the protocols for using zebrafish embryos to profile replication timing. This protocol can be easily adapted to study replication timing in mutants, individual cell types, disease models, and other species.

Zebra balığı bir Vivo içinde Model sistemi olarak kullanarak DNA çoğaltma zamanlaması profil oluşturma

DNA replication timing is an important cellular characteristic, exhibiting significant relationships with chromatin structure, transcription, and DNA ...

Highly Efficient Gene Disruption of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9

Advances in the hematopoietic stem cell (HSCs) field have been aided by methods to genetically engineer primary progenitor cells as well as animal models. Complete gene ablation in HSCs required the generation of knockout mice from which HSCs could be isolated, and gene ablation in primary human HSCs was not possible. Viral transduction could be used for knock-down approaches, but these suffered from variable efficacy. In general, genetic manipulation of human and mouse hematopoietic cells was hampered by low efficiencies and extensive time and cost commitments. Recently, CRISPR/Cas9 has dramatically expanded the ability to engineer the DNA of mammalian cells. However, the application of CRISPR/Cas9 to hematopoietic cells has been challenging, mainly due to their low transfection efficiencies, the toxicity of plasmid-based approaches and the slow turnaround time of virus-based protocols.
A rapid method to perform CRISPR/Cas9-mediated gene editing in murine and human hematopoietic stem and progenitor cells with knockout efficiencies of up to 90% is provided in this article. This approach utilizes a ribonucleoprotein (RNP) delivery strategy with a streamlined three-day workflow. The use of Cas9-sgRNA RNP allows for a hit-and-run approach, introducing no exogenous DNA sequences in the genome of edited cells and reducing off-target effects. The RNP-based method is fast and straightforward: it does not require cloning of sgRNAs, virus preparation or specific sgRNA chemical modification. With this protocol, scientists should be able to successfully generate knockouts of a gene of interest in primary hematopoietic cells within a week, including downtimes for oligonucleotide synthesis. This approach will allow a much broader group of users to adapt this protocol for their needs.

A protocol for fast CRISPR/Cas9-mediated gene disruption in mouse and human primary hematopoietic cells is described in this article. Cas9-sgRNA ribonucleoproteins are introduced via electroporation with sgRNAs generated through in vitro transcription and commercial Cas9. High editing efficiencies are achieved with limited time and financial cost.

Fare ve insan hematopoetik progenitör hücre tarafından CRISPR/Cas9 yüksek verimli Gene bozulma

Advances in the hematopoietic stem cell (HSCs) field have been aided by methods to genetically engineer primary progenitor cells as well as animal models. ...

A Combinatorial Single-cell Approach to Characterize the Molecular and Immunophenotypic Heterogeneity of Human Stem and Progenitor Populations

Immunophenotypic characterization and molecular analysis have long been used to delineate heterogeneity and define distinct cell populations. FACS is inherently a single-cell assay, however prior to molecular analysis, the target cells are often prospectively isolated in bulk, thereby losing single-cell resolution. Single-cell gene expression analysis provides a means to understand molecular differences between individual cells in heterogeneous cell populations. In bulk cell analysis an overrepresentation of a distinct cell type results in biases and occlusions of signals from rare cells with biological importance. By utilizing FACS index sorting coupled to single-cell gene expression analysis, populations can be investigated without the loss of single-cell resolution while cells with intermediate cell surface marker expression are also captured, enabling evaluation of the relevance of continuous surface marker expression. Here, we describe an approach that combines single-cell reverse transcription quantitative PCR (RT-qPCR) and FACS index sorting to simultaneously characterize the molecular and immunophenotypic heterogeneity within cell populations.
In contrast to single-cell RNA sequencing methods, the use of qPCR with specific target amplification allows for robust measurements of low-abundance transcripts with fewer dropouts, while it is not confounded by issues related to cell-to-cell variations in read depth. Moreover, by directly index-sorting single-cells into lysis buffer this method, allows for cDNA synthesis and specific target pre-amplification to be performed in one step as well as for correlation of subsequently derived molecular signatures with cell surface marker expression. The described approach has been developed to investigate hematopoietic single-cells, but have also been used successfully on other cell types.
In conclusion, the approach described herein allows for sensitive measurement of mRNA expression for a panel of pre-selected genes with the possibility to develop protocols for subsequent prospective isolation of molecularly distinct subpopulations.

Bulk gene expression measurements cloud individual cell differences in heterogeneous cell populations. Here, we describe a protocol for how single-cell gene expression analysis and index sorting by Florescence Activated Cell Sorting (FACS) can be combined to delineate heterogeneity and immunophenotypically characterize molecularly distinct cell populations.

Bir moleküler karakterize etmek için Kombinatorik tek hücreli yaklaşım ve insan kök ve yaratıcı nüfus Immunophenotypic heterojen

Immunophenotypic characterization and molecular analysis have long been used to delineate heterogeneity and define distinct cell populations. FACS is ...

Isolation, Characterization and MicroRNA-based Genetic Modification of Human Dental Follicle Stem Cells

To date, several stem cell types at different developmental stages are in the focus for the treatment of degenerative diseases. Yet, certain aspects, such as initial massive cell death and low therapeutic effects, impaired their broad clinical translation. Genetic engineering of stem cells prior to transplantation emerged as a promising method to optimize therapeutic stem cell effects. However, safe and efficient gene delivery systems are still lacking. Therefore, the development of suitable methods may provide an approach to resolve current challenges in stem cell-based therapies.
The present protocol describes the extraction and characterization of human dental follicle stem cells (hDFSCs) as well as their non-viral genetic modification. The postnatal dental follicle unveiled as a promising and easily accessible source for harvesting adult multipotent stem cells possessing high proliferation potential. The described isolation procedure presents a simple and reliable method to harvest hDFSCs from impacted wisdom teeth. Also this protocol comprises methods to define stem cell characteristics of isolated cells. For genetic engineering of hDFSCs, an optimized cationic lipid-based transfection strategy is presented enabling highly efficient microRNA introduction without causing cytotoxic effects. MicroRNAs are suitable candidates for transient cell manipulation, as these small translational regulators control the fate and behavior of stem cells without the hazard of stable genome integration. Thus, this protocol represents a safe and efficient procedure for engineering of hDFSCs that may become important for optimizing their therapeutic efficacy.

This protocol describes the transient genetic engineering of dental stem cells extracted from the human dental follicle. The applied non-viral modification strategy may become a basis for the improvement of therapeutic stem cell products.

Yalıtım, karakterizasyonu ve insan diş kökü kök hücrelerin genetik değişiklik mikroRNA tabanlı

To date, several stem cell types at different developmental stages are in the focus for the treatment of degenerative diseases. Yet, certain aspects, such ...

Endogenous Protein Tagging in Human Induced Pluripotent Stem Cells Using CRISPR/Cas9

A protocol is presented for generating human induced pluripotent stem cells (hiPSCs) that express endogenous proteins fused to in-frame&#160;N- or C-terminal fluorescent tags. The prokaryotic CRISPR/Cas9 system (clustered regularly interspaced short palindromic repeats/CRISPR-associated 9) may be used to introduce large exogenous sequences into genomic loci via homology directed repair (HDR). To achieve the desired knock-in, this protocol employs the ribonucleoprotein (RNP)-based approach where wild type Streptococcus pyogenes Cas9 protein, synthetic 2-part guide RNA (gRNA), and a donor template plasmid are delivered to the cells via electroporation. Putatively edited cells expressing the fluorescently tagged proteins are enriched by fluorescence activated cell sorting (FACS). Clonal lines are then generated and can be analyzed for precise editing outcomes. By introducing the fluorescent tag at the genomic locus of the gene of interest, the resulting subcellular localization and dynamics of the fusion protein can be studied under endogenous regulatory control, a key improvement over conventional overexpression systems. The use of hiPSCs as a model system for gene tagging provides the opportunity to study the tagged proteins in diploid, nontransformed cells. Since hiPSCs can be differentiated into multiple cell types, this approach provides the opportunity to create and study tagged proteins in a variety of isogenic cellular contexts.

Described here is a protocol for tagging endogenously expressed proteins with fluorescent tags in human induced pluripotent stem cells using CRISPR/Cas9. Putatively edited cells are enriched by fluorescence activated cell sorting and clonal cell lines are generated.

Endojen Protein insan etiketleme Pluripotent kök hücre kullanarak CRISPR/Cas9 indüklenen

A protocol is presented for generating human induced pluripotent stem cells (hiPSCs) that express endogenous proteins fused to in-frame&#160;N- or ...

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells

Hematopoietic stem and progenitor cell (HSPC) transplantation has been a cornerstone therapy for leukemia and other cancers for nearly half a century, underlies the only known cure of human immunodeficiency virus (HIV-1) infection, and shows immense promise in the treatment of genetic diseases such as beta thalassemia. Our group has developed a protocol to model HSPC gene therapy in nonhuman primates (NHPs), allowing scientists to optimize many of the same reagents and techniques that are applied in the clinic. Here, we describe methods for purifying CD34+ HSPCs and long-term persisting hematopoietic stem cell (HSC) subsets from primed bone marrow (BM). Identical techniques can be employed for the purification of other HSPC sources (e.g., mobilized peripheral blood stem cells [PBSCs]). Outlined is a 2 day protocol in which cells are purified, cultured, modified with lentivirus (LV), and prepared for infusion back into the autologous host. Key readouts of success include the purity of the CD34+ HSPC population, the ability of purified HSPCs to form morphologically distinct colonies in semisolid media, and, most importantly, gene modification efficiency. The key advantage to HSPC gene therapy is the ability to provide a source of long-lived cells that give rise to all hematopoietic cell types. As such, these methods have been used to model therapies for cancer, genetic diseases, and infectious diseases. In each case, therapeutic efficacy is established by enhancing the function of distinct HSPC progeny, including red blood cells, T cells, B cells, and/or myeloid subsets. The methods to isolate, modify, and prepare HSPC products are directly applicable and translatable to multiple diseases in human patients.

The goal of this protocol is to isolate nonhuman primate CD34+ cells from primed bone marrow, to gene-modify these cells with lentiviral vectors, and to prepare a product for infusion into the autologous host. The total protocol length is approximately 48 h.

Hazırlık ve Nonhuman primat hematopoetik kök ve progenitör hücrelerin gen modifikasyonu

Hematopoietic stem and progenitor cell (HSPC) transplantation has been a cornerstone therapy for leukemia and other cancers for nearly half a century, ...